Skip to main content
S

STARPHARMA HOLDINGS LIMITED — Investor Relations & Filings

Ticker · SPL ISIN · AU000000SPL0 LEI · 254900WRGE3OUSWGMB55 ASX Professional, scientific and technical activities
Filings indexed 42 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country AU Australia
Listing ASX SPL

About STARPHARMA HOLDINGS LIMITED

https://starpharma.com/

Starpharma Holdings Limited is a biopharmaceutical company focused on the development of dendrimer technology for pharmaceutical and life science applications. The company utilizes its proprietary DEP® (Dendrimer Enhanced Product) delivery platform to improve the performance of existing drugs by enhancing solubility, reducing toxicity, and providing targeted delivery. Its clinical-stage internal pipeline includes DEP® docetaxel, DEP® cabazitaxel, and DEP® irinotecan, primarily targeting oncology. Starpharma also markets VivaGel® BV, a non-antibiotic treatment and prevention for bacterial vaginosis, and VIRALEZE™, an antiviral nasal spray containing astodrimer sodium. The company collaborates with global pharmaceutical firms to apply its dendrimer technology to various therapeutic areas, including antibody-drug conjugates and radiopharmaceuticals.

Recent filings

Filing Released Lang Actions
FDA confirms path to DEP HER2 first-in-human study 3 pages 193.5KB
Regulatory Filings Classification · 1% confidence The document is a corporate announcement (an ASX Announcement) regarding FDA feedback on the company’s clinical development strategy for its DEP® HER2 candidate. It does not present financial results, fundraising activity, corporate governance changes, or an investor slide deck. It is a regulatory disclosure-type announcement without fitting any of the specific categories like earnings release, M&A, or board changes. Therefore it falls under the general regulatory announcements fallback category (RNS).
2026-04-20 English
Becoming a substantial holder 2 pages 180.0KB
Regulatory Filings
2026-04-14 English
Application for quotation of securities - SPL 6 pages 18.3KB
Regulatory Filings
2026-04-06 English
Ceasing to be a substantial holder 3 pages 144.1KB
Regulatory Filings
2026-03-11 English
Becoming a substantial holder 7 pages 241.2KB
Regulatory Filings
2026-03-02 English
Ceasing to be a substantial holder 3 pages 407.1KB
Regulatory Filings
2026-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.